ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION
The ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse prognosis, regardless of the chosen therapeutic strategy for the treatment of coronary disease. Traits of diagnosis and treatment of IHD in patients with renal dysfunction, including end-stage kidney d...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2017-07-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1494 |
_version_ | 1826949658900955136 |
---|---|
author | F. I. Belyalov |
author_facet | F. I. Belyalov |
author_sort | F. I. Belyalov |
collection | DOAJ |
description | The ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse prognosis, regardless of the chosen therapeutic strategy for the treatment of coronary disease. Traits of diagnosis and treatment of IHD in patients with renal dysfunction, including end-stage kidney disease, are discussed. The analysis of the studies showed increasing difficulties in the diagnosis of IHD, and decrease in the effectiveness of drug and invasive treatment.Results of large randomized and observational studies can help to treat patients with IHD and comorbid renal dysfunction more effectively and safe. |
first_indexed | 2024-03-08T14:02:21Z |
format | Article |
id | doaj.art-a84d5e28de134d8fb309a0b66ca498b1 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2025-02-17T22:17:58Z |
publishDate | 2017-07-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-a84d5e28de134d8fb309a0b66ca498b12024-12-04T11:48:13ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532017-07-0113340941510.20996/1819-6446-2017-13-3-409-4151357ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTIONF. I. Belyalov0Irkutsk State Medical Academy of Postgraduate EducationThe ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse prognosis, regardless of the chosen therapeutic strategy for the treatment of coronary disease. Traits of diagnosis and treatment of IHD in patients with renal dysfunction, including end-stage kidney disease, are discussed. The analysis of the studies showed increasing difficulties in the diagnosis of IHD, and decrease in the effectiveness of drug and invasive treatment.Results of large randomized and observational studies can help to treat patients with IHD and comorbid renal dysfunction more effectively and safe.https://www.rpcardio.online/jour/article/view/1494ischemic heart diseaserenal dysfunctionchronic kidney diseaseend-stage kidney disease |
spellingShingle | F. I. Belyalov ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION Рациональная фармакотерапия в кардиологии ischemic heart disease renal dysfunction chronic kidney disease end-stage kidney disease |
title | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
title_full | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
title_fullStr | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
title_full_unstemmed | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
title_short | ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
title_sort | ischemic heart disease and renal dysfunction |
topic | ischemic heart disease renal dysfunction chronic kidney disease end-stage kidney disease |
url | https://www.rpcardio.online/jour/article/view/1494 |
work_keys_str_mv | AT fibelyalov ischemicheartdiseaseandrenaldysfunction |